Scientific researchers can now more easily assess cell and assay quality in real-time by selecting the best individual cells for live export EMERYVILLE, Calif. — Berkeley Lights, Inc. (Nasdaq: BLI) a leader in digital cell biology, today released an upgrade to its Software Suite including enhancements to Cell Analysis Suite (CAS™), Image Analyzer, and Assay […]
The government of North Rhine-Westphalia (NRW), Germany, is supporting seven university hospitals and their cooperation partner Miltenyi Biotec in the development of cell therapies and the establishment of a state-wide infrastructure Bergisch Gladbach, Germany – An infrastructure network is being established at seven university hospitals in NRW for the implementation of novel cell therapies against […]
BC Platforms (BCP), a global leader in healthcare data management and analytics, today announced expansion of its R&D operations in Singapore, which spearheads precision medicine activities in the Asia Pacific region, including China and Japan. The company also announced a research partnership with Singapore Health Services (‘SingHealth’), Singapore’s largest public healthcare group. SingHealth has joined BCP’s BCRQUEST global […]
Extends company capabilities into nanobody and antibody discovery and development. WALTHAM, MA – Fortis Life Sciences has acquired Abcore, a San Diego, California, USA based antibody discovery platform specializing in nanobody technology. With the addition of Abcore, Fortis extends its capabilities into the antibody discovery market serving biopharma customers developing antibody and nanobody-based therapeutics. Brian […]
Cologne BioEcho Life Sciences GmbH, an innovative manufacturer of nucleic acid purification solutions for molecular diagnostics and life sciences research, today announced a minority investment from Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors. Ampersand’s investment will be used to support the company’s worldwide […]
NHS England and NHS Improvement sign two-year deal for QIAGEN’s HGMD bioinformatics HGMD (Human Gene Mutation Database) will be used at seven sites to aid interpretation of genomic data from next-generation sequencing (NGS) Deal highlights HGMD’s lead role interpreting NGS results for inherited diseases NGS data from over 2.5 million clinical cases now analyzed and […]
Next-generation mid-pilot scale peptide synthesizer provides more reliable, robust, and improved workflows Uppsala, Sweden: Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents and a pioneer in automated nanoliter-scale immunoassays, today announced the launch of PurePep® Sonata®+, a mid-pilot scale peptide synthesizer. The new system is an upgraded version of the Company’s previous model, […]
sparQ RNA-Seq HMR Kit generates high-quality Illumina® NGS sequencer-ready libraries from intact or degraded samples in a single day BEVERLY, Mass. – Quantabio, a leading provider of robust DNA and RNA amplification reagents for the most demanding molecular testing and life science research applications, today announced the commercial availability of the sparQ RNA-Seq HMR Kit, an […]
Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, today announced a partnership with Genoox, a community-driven genomic data platform, to demonstrate the clinical potential of the AVITI™ system for rare and undiagnosed disease research, using whole-genome sequencing. An initial study, in collaboration with Dr. Radha Ayyagari, Professor of Ophthalmology and Pathology at the […]
Quanterix Announces New Agreements With Lilly To Advance Alzheimer’s Disease Diagnosis And Treatment
License agreement provides Quanterix access to Lilly’s P-tau217 antibody technology, creating pathways for plasma-based biomarkers for use in Alzheimer’s disease; Establishes framework for future collaboration and supports development of Quanterix tests to advance diagnosing and treating life-threatening diseases Billerica, Mass. – Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
